SGI
RMD icon

Summit Global Investments’s ResMed RMD Stock Holding History

Summit Global Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,270
Closed -$290K – 560
2024
Q4 		$290K Buy
+1,270
New +$306K 0.02% 454
2023
Q4 		– Sell
-8,363
Closed -$1.24M – 580
2023
Q3 		$1.24M Buy
8,363
+1,267
+18% +$229K 0.08% 180
2023
Q2 		$1.55M Buy
7,096
+5,864
+476% +$1.31M 0.1% 159
2023
Q1 		$270K Buy
1,232
+22
+2% +$4.77K 0.02% 449
2022
Q4 		$252K Buy
+1,210
New +$266K 0.02% 417
2019
Q1 		– Sell
-7,840
Closed -$893K – 305
2018
Q4 		$893K Sell
7,840
-490
-6% -$52.5K 0.14% 107
2018
Q3 		$961K Buy
8,330
+750
+10% +$82.2K 0.13% 116
2018
Q2 		$785K Sell
7,580
-400
-5% -$40.5K 0.12% 115
2018
Q1 		$786K Sell
7,980
-1,830
-19% -$173K 0.13% 85
2017
Q4 		$831K Hold
9,810
– – 0.13% 102
2017
Q3 		$755K Buy
9,810
+1,220
+14% +$93.3K 0.12% 119
2017
Q2 		$669K Buy
8,590
+850
+11% +$60.8K 0.2% 75
2017
Q1 		$557K Buy
+7,740
New +$535K 0.18% 95

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Summit Global Investments's RMD Position: Q1 2025 in Review

Summit Global Investments sold out of ResMed (RMD) in Q1 2025, closing a stake of 1,270 shares — an estimated $290K sold.

Summit Global Investments first reported a position in RMD in Q1 2017 and held it in 13 quarters. The position peaked at $1.55M in Q2 2023. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Summit Global Investments reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Summit Global Investments sold 1,270 ResMed shares in Q1 2025, an estimated $290K.
  • Summit Global Investments first reported a position in ResMed in Q1 2017 and held it in 13 quarters.
  • Summit Global Investments's ResMed position peaked at $1.55M in Q2 2023.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Summit Global Investments's 13F filing for Q1 2025, filed 7 Apr 2025.